首页|探讨审方药师医嘱审核干预对不合理用药的影响

探讨审方药师医嘱审核干预对不合理用药的影响

扫码查看
目的 分析审方药师医嘱审核干预对不合理用药的影响.方法 选择静配中心 2021 年117118 份医嘱和 2022 年 127747 份医嘱进行分析,2021 年未采取审方药师医嘱审核干预,2022 年采取审方药师医嘱审核干预.比较 2021、2022 年静配中心不合理医嘱发生情况.结果 2022 年静配中心不合理医嘱发生率 0.49%低于 2021 年的 0.85%,差异具有统计学意义(P<0.05).结论 不合理医嘱主要为溶媒选择不当、溶媒量不适宜、给药剂量不适宜、给药频次不适宜、配伍不当等,审方药师通过对医嘱进行审核,采取有效措施对不合理用药情况进行干预,能够保证临床合理用药,保证患者用药安全性.
Exploring the influence of prescription reviewer's intervention in medical order review on unreasonable drug use
Objective To analyze the influence of prescription reviewer's intervention in medical order review on unreasonable drug use.Methods 117 118 medical orders from pharmacy intravenous admixture services in 2021 and 127 747 orders in 2022 were selected for analysis.In 2021,there was no prescription reviewer's intervention in medical order review,and in 2022,there was prescription reviewer's intervention in medical order review.The unreasonable medical orders in pharmacy intravenous admixture services in 2021 and 2022 were compared.Results The incidence of unreasonable medical orders in 2022 was 0.49%,which was lower than 0.85%in 2021,and the difference was statistically significant(P<0.05).Conclusion Unreasonable medical advice mainly includes improper selection of solvent,inappropriate solvent dosage,inappropriate dosage,inappropriate frequency of administration,and improper compatibility.By reviewing medical orders and taking effective measures to intervene in unreasonable drug use,pharmacists can ensure rational clinical medication and the safety of patient medication.

Pharmacy intravenous admixture servicesPrescription reviewerIntervention in medical order reviewUnreasonable medical orders

张银霞

展开 >

213000 常州市第二人民医院

静配中心 审方药师 医嘱审核干预 不合理医嘱

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(18)